Your session is about to expire
← Back to Search
AUS vs ATOMS for Urinary Incontinence
Study Summary
This trial will compare the effectiveness of two treatments for post-prostatectomy incontinence: an artificial urinary sphincter (AUS) or an adjustable transobturator male sling (ATOMS).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have incontinence caused by a nerve-related issue.My doctor thinks surgery or anesthesia is risky for me due to my physical or mental condition.I agreed to be randomly assigned to receive either ATOMS or AUS treatment.I experience light incontinence, less than 200g per day.I am allergic to rifampin, minocycline HCl, or other tetracyclines.I am a man over 18 with severe urinary issues after prostate surgery and have agreed to more surgery.I haven't had unresolved narrowing of my urethra or bladder connection in the past year.I have had surgery for incontinence before.I have urinary incontinence caused by a permanent blockage in my lower urinary tract.Your PSA levels have been increasing in the past year.
- Group 1: Adjustable Transobturator Male System
- Group 2: Artificial Urinary Sphincter
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor recruiting participants at the present time?
"Indeed, the information hosted on clinicaltrials.gov corroborates that this research project is presently looking for participants. Initially posted on January 13th 2022, it has been updated as recently as July 14th 2022 and seeks to enroll 60 patients from a single centre."
How many participants are currently signed up for this research study?
"Affirmative. Information found on clinicaltrials.gov indicates that this experiment, which went live in January 13th 2022, is actively pursuing participants for enrollment. Sixty individuals should be recruited from one site to complete the trial."
Share this study with friends
Copy Link
Messenger